PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
🔒 Subscribers only
AUTH/2211/3/09
Off-label Promotion Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Boehringer Ingelheim Limited — Micardis (telmisartan); Micardis Plus (telmisartan/hydrochlorothiazide)
A general practitioner complained about a journal advertisement for Micardis (telmisartan) and Micardis Plus (telmisartan/hydrochlorothiazide) issued by Boehringer Ingelheim Limited, appearing in P…
Clauses: 3.2,7.2,7.4,7.10
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2210/3/09
HCP Hospitality & Meetings Not Upheld 🏥 Other ▶ Video 🎙 Podcast
AstraZeneca UK Limited — Not stated
An anonymous, uncontactable general practitioner complained about the conduct of a named AstraZeneca representative.The complainant alleged the representative owned and ran a popular local bar/rest…
Clauses: 2,9.1,19.1,15.2
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2208/2/09
Data & Publications Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Gilead Sciences Ltd — Not stated
A health professional complained he received an unsolicited email from Gilead Sciences Ltd and said he had not provided his email address to Gilead.He asked Gilead how it obtained his personal emai…
Clauses: 9.9,9.1
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2207/2/09
Data & Publications Upheld 🏥 Oncology ▶ Video 🎙 Podcast
ProStrakan Ltd — Abstral (sublingual fentanyl citrate tablet)
Cephalon (UK) Limited complained about ProStrakan Ltd’s promotion of Abstral (sublingual fentanyl citrate tablet).The materials at issue were two leavepieces (refs MO17/0070 and MO17/0101).The cl…
Clauses: 3.2
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2206/2/09
HCP Hospitality & Meetings Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
AstraZeneca — Crestor (rosuvastatin)
AstraZeneca voluntarily admitted that a dispensing account manager sent an unapproved promotional email for Crestor (rosuvastatin) to a dispensing practice/health professional in response to an enq…
Clauses: 3.2,4.1,7.2,7.4,7.9,7.10,9.1,14.1,2
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2204/1/09
Data & Publications Upheld 🏥 Oncology ▶ Video 🎙 Podcast
AstraZeneca Zoladex
The MHRA complained about a Zoladex (goserelin) journal advertisement (ref AZ-CZ000261b-ZOLU) issued by AstraZeneca UK Limited.The advertisement appeared in The Pharmaceutical Journal on 17 January…
Clauses: 27.3
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2203/1/09
Data & Publications Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Pfizer
Johnson & Johnson Limited complained about a Champix (varenicline) journal advertisement (ref CHA432a) issued by Pfizer Limited and published in GP on 11 April 2008.The advertisement included t…
Clauses: 9.1,26.1
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2202/1/09
Patient Organisations Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk diabetes supplement in The Times
Eli Lilly and Company Limited complained about an article, “Gut protein drug expected to help improve control”, in a 16-page diabetes supplement (“Changing the Future of Diabetes”) distribu…
Clauses: 9.1,9.2
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2201/1/09
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Novartis
AstraZeneca UK Limited complained about a UK press release (ref FEM08000117) issued by Novartis Pharmaceuticals UK Ltd, dated 11 December, headed: “Femara (letrozole) FIRST aromatase inhibitor to…
Clauses: NONE
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2199/1/09
Data & Publications Not Upheld 🏥 Musculoskeletal & Bone ▶ Video 🎙 Podcast
Novartis v Roche
Novartis complained about an 8-page Roche promotional leavepiece for Bondronat (ibandronate), used by the hospital sales force with oncologists and breast care nurses, comparing against zoledronic …
Clauses: NONE
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2197/1/09
Social Media & Digital Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
MASTA
Sanofi Pasteur MSD complained about an email headed “Epaxal costings” sent by a MASTA representative to a customer in October 2008.Although framed as cost information, the email contained multi…
Clauses: 4.1,9.1,12.1
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2196/1/09
Off-label Promotion Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
AstraZeneca Arimidex mailing
An anonymous, uncontactable oncologist complained about a promotional mailing for Arimidex (anastrozole) sent by AstraZeneca UK Limited (mailer ref C15822).The mailing included a leaflet about the …
Clauses: NONE
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2223/4/09
Data & Publications Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Allergan
A member of the public complained about the promotion of Juvederm Ultra.The case was assessed under the ABPI Code of Practice (Applicable Code year: 2008).The PMCPA concluded the matter was outwith…
Clauses: NONE
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2242/6/09
HCP Hospitality & Meetings Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Takeda
A primary care pharmacist complained about alleged advertising of an unlicensed medicine by Takeda.The PMCPA concluded the matter was outwith the scope of the Code.
Clauses: NONE
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2284/12/09
Data & Publications Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Norgine
An anonymous nurse made a complaint about Norgine.The PMCPA concluded the matter was outwith the scope of the ABPI Code of Practice.No case report was issued because it was outwith scope.
Clauses: NONE
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2286/12/09
Data & Publications Not Upheld 🏥 Other ▶ Video 🎙 Podcast
GlaxoSmithKline
A General Practitioner complained about GlaxoSmithKline.The subject matter was sponsorship of drug testing in sport.The PMCPA concluded the complaint was outwith the scope of the ABPI Code of Pract…
Clauses: NONE
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2270/10/09
HCP Hospitality & Meetings Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Merz Pharma
Allergan complained about Merz Pharma UK Ltd’s promotion of Xeomin (botulinum neurotoxin type A).An exhibition panel at the Association of British Neurologists meeting (Liverpool, June 2009) stat…
Clauses: NONE
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2271/10/09
HCP Hospitality & Meetings Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Roche
Roche voluntarily admitted that an advertisement for Avastin (bevacizumab) was published in the BMJ throughout September before it had been fully certified.The failure occurred because a single emp…
Clauses: NONE
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2268/9/09
Data & Publications Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
ProStrakan
Cephalon complained that a ProStrakan advertisement for Abstral (sublingual fentanyl citrate) appeared in the BMJ on 12 September 2009, despite undertakings given in earlier cases (AUTH/2207/2/09 a…
Clauses: NONE
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2264/9/09
HCP Hospitality & Meetings Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK satellite symposium invitation at ESC 2009
An anonymous complainant (“Unhappy Physician”) picked up an invitation from GlaxoSmithKline’s exhibition stand at the European Society of Cardiology (ESC) Congress, Barcelona 2009, to a satel…
Clauses: NONE
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2263/9/09
Off-label Promotion Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Boehringer Ingelheim
Bristol-Myers Squibb complained about a Boehringer Ingelheim journal advertisement for Viramune (nevirapine) in HIV Medicine, July 2009.The ad used “Have you heard?” and “New Viramune data wi…
Clauses: NONE
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2261/9/09
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
MSD breach of undertaking after withdrawn Cozaar banner reappeared in MIMS update (AUTH/2261/9/09)
Merck Sharp & Dohme (MSD) had previously given an undertaking in Case AUTH/2212/3/09 after a Cozaar (losartan) claim was ruled misleading.MSD instructed the publisher of MIMS Monthly Update to …
Clauses: NONE
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2260/9/09
Data & Publications Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Boehringer Ingelheim rep emailed misleading/disparaging claims about Xarelto (rivaroxaban)
Boehringer Ingelheim voluntarily admitted that a representative emailed a consultant orthopaedic surgeon with information about Bayer’s Xarelto (rivaroxaban) that could be seen as misleading and …
Clauses: NONE
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2256/8/09
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Napp
A health and social care board prescribing adviser complained about a Targinact (prolonged release oxycodone/naloxone) presentation on a Napp-sponsored website (www.targetingpain.co.uk).Slide 7 (�…
Clauses: NONE
2009 🔒 Subscribe
← Prev 54 55 56 57 58 59 60 Next → Page 57 of 73 — 1752 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews